LGND
NASDAQ
$293.99
Ligand Pharmaceuticals Inc - Class B (LGND)
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs globally. The company is headquartered in San Diego, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $311.30 (+5.89%)
Market Cap
$5.93B
EPS 5Y CAGR
+26.59%
FCF 5Y CAGR
+22.85%
Forward P/E
34.01
Price Chart
Valuation
Market Cap$5.93B
P/E37.91
Forward P/E34.01
PEG1.53
P/S21.98
P/B6.21
Profitability
Total Revenue (TTM)$274M
Gross Profit (TTM)$228M
EBITDA$128M
Profit Margin-25.8%
Operating Margin33.6%
EPS$7.81
Financial Health
Free Cash Flow Yield2.07%
Growth & Risk
EPS 5Y CAGR+26.59%
Revenue 5Y CAGR+8.15%
FCF 5Y CAGR+22.85%
Beta (5Y)0.96
Sharpe Ratio2.15